Navigation Links
Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
Date:8/19/2007

Faith-based program provides ministry with tools and information to sustain

efforts in hepatitis C education, screening and testing

PHILADELPHIA, Aug. 17 /PRNewswire-USNewswire/ -- Roche representatives will work together with the Enon Tabernacle Baptist Church from Saturday, August 18 - Sunday, August 19 to educate the church community about the hepatitis C virus (HCV), including risk factors, the importance of getting tested and possible treatment options.

Preparations will begin on Friday, August 17 when ministry leaders, church volunteers, and Roche representatives convene to review education and testing logistics regarding HCV.

"African Americans have the highest rate of infection with hepatitis C in the country. We are committed to educate and provide free hepatitis C testing to the members of Enon Tabernacle Baptist Church and other local residents to prevent future infections," said Senior Pastor Rev. Dr. Alyn E. Waller, Enon Tabernacle Baptist Church, Philadelphia, PA.

For the past four years, Roche has worked primarily with African-American community churches nationwide to establish HCV testing programs in congregations across the country. In 2006, screening events took place in 30 communities of faith, and an additional 80 events are scheduled in 2007, with the program also extending to Hispanic and Egyptian churches.

"At Roche, we are dedicated to improving the lives of patients and to the communities where they live and worship," said Frank Griffith, Brand Director, Interferons Marketing, Roche. "By providing this congregation with the tools and information it needs to execute HCV education and screenings, it can successfully sustain this valuable community program in the future."

About HCV

According to the American Liver Foundation, more than four million people in the United States are or have been infected with hepatitis C, and an estimated 70 percent are not aware they have the virus.

Hepatitis C is one of six identified hepatitis viruses that cause the liver to become inflamed, which interferes with its ability to function, and is generally considered to be among the most serious of the six hepatitis viruses.(1) HCV is transmitted primarily through direct exposure to blood through an opening in the skin or mucus membrane. The hepatitis C virus infects the liver, causing inflammation resulting in damage of the liver tissue.(2) Many people with chronic hepatitis C have no symptoms of liver disease, but if symptoms are present they are usually mild; may come and go over time; and be hard to recognize as related to hepatitis C. Symptoms may include fatigue, liver pain, nausea, poor appetite or muscle and joint pains.(3) Contact your physician if you experience any of these symptoms.

Additional information about hepatitis C can be found by calling the American Liver Foundation at toll-free 800-GO-Liver (465-4837) or 888-4HEP-USA (443-7872), by visiting its Web site at http://www.liverfoundation.org or by visiting Roche's site: http://www.pegasys.com .

(1) Mayoclinic.com. September 14, 2005.

http://www.mayoclinic.com/health/hepatitis-c/DS00097. Accessed on July

25, 2006.

(2) American Liver Foundation. Copyright 2002-2003.

http://www.liverfoundation.org/db/articles/1063. Accessed on July 26,

2006

(3) National Digestive Diseases Information Clearinghouse (NDDIC).

February 2003.

http://digestive.niddk.nih.gov/ddiseases/pubs/chronichepc/index.htm#C.

Accessed on July 26, 2006.

About Roche

Hoffmann-La Roche Inc. (Roche), based in Nutley, N.J., is the U.S. pharmaceuticals headquarters of the Roche Group, one of the world's leading research-oriented healthcare groups with core businesses in pharmaceuticals and diagnostics. For more than 100 years, the Roche Group has been committed to developing innovative products and services that address prevention, diagnosis and treatment of diseases, thus enhancing people's health and quality of life. An employer of choice, in 2006, Roche was named one of the Top 20 Employers (Science magazine), ranked the No. 1 Company to Sell For (Selling Power), and one of AARP's Top Companies for Older Workers, and in 2005, Roche was named one of Fortune magazine's Best Companies to Work For in America. For additional information about the U.S. pharmaceuticals business, visit our websites: http://www.rocheusa.com or http://www.roche.us.


'/>"/>
SOURCE Roche

Copyright©2007 PR Newswire.

Related biology technology :

1. Advantages of Roche Applied Science amplification products
2. Roche Diagnostics Corporation
3. Roche Diagnostics Corporation
4. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
5. Prodesse enters patent agreement with Roche
6. Chemical-petroleum executive joins Virent Energy board
7. Schneider National exec joins TrafficCast board
8. Doyle joins governors in support of stem cell bill
9. Genomics researcher Hood joins NimbleGen board
10. Fergus joins Baird Venture Partners, Caden Bio
11. Meier joins Broadlook Technologies as COO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... February 10, 2016 , ... ... registry built on the secure online PatientCrossroads platform, has exceeded both its one-year ... have joined the PROMPT study, which seeks to advance understanding of the hereditary ...
(Date:2/10/2016)... CA (PRWEB) , ... February 10, 2016 , ... Cenna ... agents for the treatment of Alzheimer’s disease, announced today it has been selected to ... 18th at the Breakers in Palm Beach, Florida. The purpose of the Forum ...
(Date:2/9/2016)... , Feb. 9, 2016  Regenicin, Inc. (OTC ... specializing in the development and commercialization of regenerative ... tissues and organs, recently reported the Company,s operating ... quarter of 2016. Lonza America , ... 2015 fiscal year in the process of consummating ...
(Date:2/9/2016)... , ... February 09, 2016 , ... ... latest innovations on its free and validated Electronic Data Capture (EDC) system ClinCaptureand ... Outsourcing in Clinical Trials West Coast 2016 Conference in San Mateo, California on ...
Breaking Biology Technology:
(Date:2/3/2016)... -- --> --> Fourth quarter 2015: ... 1,187% compared with fourth quarter of 2014. Gross margin was ... 30.0). Earnings per share increased to SEK 6.39 (loss: 0.49). ... 74.7). , --> --> ... M (233.6), up 1,142% compared with 2014. Gross margin was ...
(Date:2/3/2016)... 2016 http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ... "Emotion Detection and Recognition Market by ... Software Tools (Facial Expression, Voice Recognition and ... - Global forecast to 2020" report ... http://www.researchandmarkets.com/research/d8zjcd/emotion_detection ) has announced the addition of ...
(Date:2/2/2016)... Feb. 2, 2016 Checkpoint Inhibitors for ... Market Are you interested in the future ... for checkpoint inhibitors. Visiongain,s report gives those predictions ... and national level. Avoid falling behind in ... opportunities and revenues those emerging cancer therapies can ...
Breaking Biology News(10 mins):